Medtronic plc - Common Stock (MDT)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MDT on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
1,282,559,305
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,073,469,026
Holdings value
$102,242,162,094
% of all portfolios
0.091%
Number of holders
2,134
Number of buys
1,070
Number of sells
-932
Average buys %
+0.01%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Medtronic plc - Common Stock (MDT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10.21% $11,837,817,172 130,949,305 The Vanguard Group 28 Nov 2025
BlackRock, Inc. 6.9% $7,461,254,034 88,655,585 BlackRock, Inc. 31 Mar 2025

Institutional Holders of Medtronic plc - Common Stock (MDT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1,073,469,026 $102,242,162,094 -$652,993,840 $95.24 2,134
2025 Q2 1,082,670,216 $94,409,229,514 +$1,865,086,187 $87.17 2,114
2025 Q1 1,060,189,456 $95,237,696,116 +$125,218,666 $89.86 2,137
2024 Q4 1,064,183,008 $85,080,326,911 +$703,263,540 $79.88 2,095
2024 Q3 1,048,334,210 $94,383,151,962 -$699,342,905 $90.03 2,035
2024 Q2 1,058,327,951 $83,342,475,135 -$2,758,106,144 $78.71 1,999
2024 Q1 1,093,749,433 $95,270,041,268 +$387,164,315 $87.15 2,048
2023 Q4 1,087,965,051 $89,660,249,885 -$269,861,428 $82.38 2,048
2023 Q3 1,090,697,745 $85,465,926,428 +$293,375,202 $78.36 1,947
2023 Q2 1,086,574,033 $95,680,614,824 -$385,945,404 $88.1 2,029
2023 Q1 1,090,277,471 $87,892,843,380 +$696,533,584 $80.62 1,958
2022 Q4 1,082,281,283 $84,167,427,180 -$246,934,545 $77.72 1,924
2022 Q3 1,084,715,436 $87,724,015,453 +$1,292,460,429 $80.75 1,894
2022 Q2 1,065,231,354 $95,620,261,433 -$180,696,284 $89.75 1,975
2022 Q1 1,073,180,822 $119,091,032,435 -$194,091,137 $110.95 2,066
2021 Q4 1,075,569,610 $111,347,528,661 -$193,274,037 $103.45 2,019
2021 Q3 1,074,115,701 $134,673,451,142 -$643,717,494 $125.35 1,981
2021 Q2 1,080,003,441 $134,083,042,145 -$524,988,822 $124.13 1,957
2021 Q1 1,083,209,356 $127,976,659,297 +$640,958,996 $118.13 1,929
2020 Q4 1,075,833,662 $126,008,600,860 -$139,830,178 $117.14 1,907
2020 Q3 1,081,915,335 $112,412,998,502 -$1,213,691,421 $103.92 1,771
2020 Q2 1,091,580,345 $100,168,948,058 -$112,204,884 $91.7 1,715
2020 Q1 1,093,396,485 $98,660,486,121 -$664,484,689 $90.18 1,710
2019 Q4 1,099,875,362 $124,831,623,943 +$1,088,629,181 $113.45 1,771
2019 Q3 1,089,396,290 $118,351,693,998 -$342,497,982 $108.62 1,601
2019 Q2 1,092,695,517 $106,413,152,178 +$2,258,111,272 $97.39 1,572
2019 Q1 1,079,286,822 $98,322,678,939 -$680,264,420 $91.08 1,553
2018 Q4 1,087,654,081 $98,967,064,105 -$912,349,694 $90.96 1,517
2018 Q3 1,096,831,309 $107,891,802,174 +$2,119,393,406 $98.37 1,442
2018 Q2 1,075,722,205 $92,090,921,226 -$1,792,773,789 $85.61 1,364
2018 Q1 1,095,654,757 $87,886,197,172 -$226,411,573 $80.22 1,333
2017 Q4 1,101,228,648 $88,931,775,379 -$1,124,204,032 $80.75 1,353
2017 Q3 1,116,313,005 $86,823,840,096 +$1,179,267,682 $77.77 1,234
2017 Q2 1,107,563,057 $98,352,488,805 -$1,230,635,786 $88.75 1,226
2017 Q1 1,128,163,040 $90,907,873,262 +$6,407,131,266 $80.56 1,225
2016 Q4 1,136,070,757 $80,940,595,889 +$5,430,063,568 $71.23 1,210
2016 Q3 1,050,670,429 $90,739,403,183 -$1,834,333,446 $86.4 1,195
2016 Q2 1,065,797,423 $92,473,844,125 -$43,846,000 $86.77 1,180
2016 Q1 1,064,962,814 $79,867,770,733 -$555,455,029 $75 1,155
2015 Q4 1,079,297,028 $83,028,254,448 -$1,322,095,259 $76.92 1,160
2015 Q3 1,092,906,719 $73,169,912,001 +$839,500,993 $66.94 1,106
2015 Q2 1,084,585,344 $80,367,887,165 -$1,011,284,875 $74.1 1,144
2015 Q1 1,096,105,576 $85,485,291,199 +$83,549,148,792 $77.99 1,080
2014 Q4 24,685,038 $1,782,400,607 +$1,424,749,015 $72.2 96
2014 Q3 4,575,414 $283,446,000 -$9,430,396 $61.95 8
2014 Q2 4,727,254 $301,410,000 +$290,193,754 $63.76 7
2014 Q1 191,962 $12,028,598 +$824,650 $61.54 8